About Symphogen AS
Symphogen AS is a clinical-stage antibody oncology-focused company. It develops innovative therapies for the treatment of cancer and other significant diseases. It was founded in 2000 and based in Denmark.
2000
Founded
Year established
2
Transactions
Sign up to view
Investors
Current Investors
Servier
••••••••
Past Investors
••••••••
••••••••
Investment Details
2 Transactions
| Trans. ID | Investment Date | Exit Date | Investor(s) | Deal Size (M) | Seller(s) |
|---|---|---|---|---|---|
Symphogen AS M&A Activity
| # | Company | Transaction Date | Close Date | Sector | Country |
|---|---|---|---|---|---|
|
|
|||||
|
|
|||||
|
|
|||||
|
|
Key Executives & Professionals
Frequently Asked Questions
What does Symphogen AS do?
Symphogen AS is a clinical-stage antibody oncology-focused company. It develops innovative therapies for the treatment of cancer and other significant diseases. It was founded in 2000 and based in Denmark.
Where is Symphogen AS headquartered?
Symphogen AS is headquartered in Lyngby,, Denmark.
When was Symphogen AS founded?
Symphogen AS was founded in 2000.
What sector is Symphogen AS in?
Symphogen AS operates in the Life Science sector.
Who are the investors in Symphogen AS?
Current investors in Symphogen AS include Servier. Sign up to AcquityData to view full investor details, deal dates and transaction history.
How many M&A transactions has Symphogen AS been involved in?
Symphogen AS has 2 transactions tracked on AcquityData. Sign up to view full investment history including dates, deal sizes, investors and sellers.
Unlock the full Symphogen AS profile
Ownership & Investors
M&A History
Financials
Key Executives
Advisors & Lenders
Access Symphogen AS's complete ownership history, M&A activity, investors, advisors and executives in one connected platform.
Start Free Trial